How Uremic Toxins Alter Atorvastatin Disposition: Molecular Mechanisms of Inhibition of the Enzyme CYP3A4
Background: In uremic patients, the accumulation of gut-derived protein-bound uremic toxins (PBUTs) induces changes in the microenvironment of the patients, leading to changes in the elimination pattern of drugs. Aims: To assess ways in which PBUTs alter the CYP450 enzymes in hepatocytes as well as...
Saved in:
| Main Authors: | Ashna Asim, Fen Wang, Dong Pu, Sisi Wang, Dian Wang, Wenwen Li, Feng Yu, Li Ji |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Publishing House
2025-01-01
|
| Series: | Balkan Medical Journal |
| Online Access: | https://balkanmedicaljournal.org/text.php?lang=en&id=2669 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Future of Uremic Toxin Management
by: Raymond Vanholder, et al.
Published: (2024-10-01) -
Alterations in gut‐derived uremic toxins before the onset of azotemic chronic kidney disease in cats
by: Laurens Van Mulders, et al.
Published: (2025-01-01) -
Adsorption of uremic toxins over dealuminated zeolites
by: Bachar Koubaissy, et al.
Published: (2017-03-01) -
Metabolomics reveals alterations in gut-derived uremic toxins and tryptophan metabolism in feline chronic kidney disease
by: Laurens Van Mulders, et al.
Published: (2025-12-01) -
The Choice of Anti-Inflammatory Influences the Elimination of Protein-Bound Uremic Toxins
by: Víctor Joaquín Escudero-Saiz, et al.
Published: (2024-12-01)